Skip to main content

MoneyWorks4Me

Clarification sought from Lupin

09 May 2017 Evaluate

The Exchange has sought clarification from Lupin with respect to news article appearing on CNBC TV18 on May 9, 2017 titled ‘USFDA issues 8 observations for Lupin Aurangabad Plant’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..